{"id":"W4323035289","doi":"10.1002/cam4.5753","title":"Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study","year":2023,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Sanofi","keywords":"Daratumumab; Multiple myeloma; Internal medicine; Medicine; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002532645,0.001821558,0.002211354,0.0005394917,0.0004617484,0.001062918,0.0009169119,0.001292321,0.002271621],"category_scores_gemma":[0.001046505,0.0007225027,0.001799335,0.0004765686,0.0007939636,0.000769737,0.0003595844,0.002933448,0.0007692178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008350246,"about_ca_system_score_gemma":0.001239763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007014822,"about_ca_topic_score_gemma":0.001160173,"domain_scores_codex":[0.999352,0.0003529729,0.00003312243,0.00009320812,0.00006080359,0.0001079594],"domain_scores_gemma":[0.9992643,0.0001160394,0.0001687345,0.00006842052,0.00004192438,0.0003405884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6520649,0.1385998,0.01701541,0.001261065,0.003079939,0.0009543021,0.0006425483,0.002812528,0.04395459,0.0003064972,0.004610978,0.1346975],"study_design_scores_gemma":[0.5430881,0.4343161,0.01584079,0.00004182507,0.0006540907,0.0005271038,0.00005202852,0.001332962,0.002000508,0.0001082747,0.002007053,0.00003105974],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947577,0.002254626,0.0002502571,0.000432058,0.00007976394,0.0008898166,0.0002969526,0.0000650902,0.0009735761],"genre_scores_gemma":[0.9925668,0.002025552,0.000839003,0.0009319269,0.0003646266,0.001119466,0.0009523511,0.00002384296,0.001176269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002532645,"threshold_uncertainty_score":0.01339406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02986163340831269,"score_gpt":0.340492628545331,"score_spread":0.3106309951370183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}